EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Increased coproporphyrin serum levels in healthy volunteers treated with the cholesterol uptake inhibitor ezetimibe

Jonny Kinzi iD, Markus Grube iD, Isabell Seibert, Werner Siegmund, Henriette E Meyer Zu Schwabedissen iD

Clinical and Translational Science · 2024

DOI: 10.1111/cts.70041 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Translational Science, 2024. Verfasst von Jonny Kinzi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Biopharmacy, Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland. Hauptthemen laut MEDLINE: Ezetimibe, Coproporphyrins, Healthy Volunteers, Rifampin. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ezetimibe undergoes glucuronidation that results in the active metabolite ezetimibe phenoxy‐glucuronide (ezetimibe‐glucuronide). This phase‐II metabolite was shown to interact with the clinically relevant hepatic transporter organic anion transporting polypeptide (OATP) 1B1. In recent years, coproporphyrin I (CPI) was established as a Tier 1 biomarker for OATP1B‐mediated interactions among other endogenous substrates like CPIII. To evaluate whether levels of the biomarker are affected by ezetimibe treatment, we assessed the impact of ezetimibe and ezetimibe‐glucuronide on OATP1B1‐mediated transport of CPs in vitro. Then, we quantified CP levels in serum samples of healthy volunteers treated with a single oral dose of ezetimibe (20 mg) alone or in combination with rifampin (600 mg). Results from our in vitro experiments showed a significant reduction in cellular CPI accumulation in the presence of ezetimibe‐glucuronide with an IC 50 of 1.97 μM [95% CI: 1.04 to 3.96], while CPIII accumulation was impacted by 10 μM and above. In the in vivo study, we observed peak CP concentrations 1.33 h after dosing, which is closest to the t max of the ezetimibe metabolite. Co‐administration of ezetimibe with rifampin resulted in even higher serum CP levels. The AUC 0–24h of CPI and CPIII increased two‐ and threefold, respectively, after concomitant dosing compared to ezetimibe alone. Moreover, we quantified CP levels in cumulative urine from both study phases where the renally excreted amount ( A e ) of CPI and CPIII increased after ezetimibe and rifampin co‐administration compared to ezetimibe alone. In conclusion, our findings indicate that rifampin co‐administration results in additional inhibition of OATP1B1 in vivo.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EzetimibeCoproporphyrinsHealthy VolunteersRifampinLiver-Specific Organic Anion Transporter 1Drug InteractionsHumansMaleAdultFemaleAnticholesteremic AgentsYoung AdultCholesterolBiomarkersHEK293 CellsMiddle AgedAzetidinesGlucuronides

Substanzen

EzetimibeCoproporphyrinsRifampinLiver-Specific Organic Anion Transporter 1SLCO1B1 protein, humancoproporphyrin IAnticholesteremic Agentsezetimibe glucuronideCholesterolBiomarkers

Autor:innen und Institutionen

  • Biopharmacy, Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland.
  • Center of Drug Absorption and Transport, Institute for Pharmacology, University Medicine Greifswald, Greifswald, Germany.

ORCID-Profile: Jonny Kinzi, Markus Grube, Henriette E Meyer Zu Schwabedissen

Zitieren

APA

Kinzi, J., Grube, M., Seibert, I., Siegmund, W., & Meyer Zu Schwabedissen, H. E. (2024). Increased coproporphyrin serum levels in healthy volunteers treated with the cholesterol uptake inhibitor ezetimibe. Clinical and Translational Science. https://doi.org/10.1111/cts.70041

Vancouver

Kinzi J, Grube M, Seibert I, Siegmund W, Meyer Zu Schwabedissen HE. Increased coproporphyrin serum levels in healthy volunteers treated with the cholesterol uptake inhibitor ezetimibe. Clinical and Translational Science. 2024. doi:10.1111/cts.70041

BibTeX
@article{Kinzi2024,
  author = {Kinzi, Jonny and Grube, Markus and Seibert, Isabell and Siegmund, Werner and Meyer Zu Schwabedissen, Henriette E},
  title = {Increased coproporphyrin serum levels in healthy volunteers treated with the cholesterol uptake inhibitor ezetimibe},
  journal = {Clinical and Translational Science},
  year = {2024},
  doi = {10.1111/cts.70041}
}
Kostenlos starten →